HermanSullivanMDMD(He/Him)
Neurology • Grand Rapids, MINeuroimmunology/Multiple Sclerosis
Executive Medical Director Hauenstein Neurosciences Medical Director, Multiple Sclerosis Clinic at Trinity Health GR
Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Cherry St SE
Grand Rapids, MI 49503Phone+1 616-685-5050
Education & Training
Stanford Health CareFellowship, 1989 - 1991
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1986 - 1989
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1985 - 1986
University of North Carolina at Chapel Hill School of MedicineClass of 1985
Harvard UniversityBS, Biochemical Sciences and Molecular Biology, 1977 - 1981
Certifications & Licensure
CA State Medical License 1989 - Present
MI State Medical License 1996 - 2025
OH State Medical License 1991 - 1996- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Clinical Trial Nuedexta in Subjects With ALS Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 188 citationsAlemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical TrialAlasdair Coles, Edward Fox, A. Vladic, Suzanne Gazda, Vesna V. Brinar
Neurology. 2012-04-03 - 39 citationsA single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosisEdward Fox, H. C. Sullivan, Suzanne Gazda, Lori Mayer, L. O'Donnell
European Journal of Neurology. 2012-02-01 - 11 citationsATP-sensitive potassium channels are not expressed in brain microvesselsHerman C. Sullivan, Sami I. Harik
Brain Research. 1993-05-28
Professional Memberships
- Member
- Member
- Member
Industry Relationships
- Medical Director, Pharmcia & UpjohnMedical director for several chemical entities in various stages of development, including pramipexole (Parkinson disease), almotriptan (migraine), and linomide (multiple sclerosis).Disclosure: None currently1995 - 1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
